Q4 2023 Earnings Call Transcript April 24, 2024 CureVac N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and ...

China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a ...

to provide insights into the vaccine effectiveness of the Pfizer-BioNTech vaccine against infections and severe disease linked to Omicron infection. Discovery Health further explored various other ...

GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the ... improvements and financial results,” Amazon CEO Andy Jassy said in a statement. The nation’s biggest ...

GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...

To hear CEO Pascal Soriot explain it ... potential for combinations including with its SGLT2 agent Farxiga. As for vaccines, AZ in December entered into an agreement to acquire Icosavax, which ...

GSK said in the lawsuit , opens new tab that Pfizer and BioNTech's Comirnaty vaccines violate the ... UnitedHealth is not too big to fail, CEO tells Senate panel 6:28 PM UTC Worldcategory US ...

A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched Thursday with $54 million in funding. Corner Therapeutics’ Series A round was led by Ziff ...

One of the world’s top vaccine-makers is partnering with a major AI company to advance medicine — and its chief executive is excited. Moderna and OpenAI announced an ongoing partnership ...